Case File №
#VI-2026-0264
Royal Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
42 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B Good | 7 | 7.0 | 5.8 | 8.9 | 16 Mar 2025 |
| Retatrutide | C Okay | 13 | 6.8 | 4.6 | 8.8 | 16 Mar 2025 |
| Tirzepatide | C Okay | 10 | 6.4 | 4.2 | 9.5 | 16 Mar 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| Alprostadil | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Anavar (Oxandrolone) | X N/A | 3 | 6.0 | 3.5 | 9.4 | 19 Jan 2026 |
| Andarine S4 | X N/A | 3 | 7.7 | 7.0 | 8.5 | 26 Jan 2026 |
| BAC Water | X N/A | 3 | 6.5 | 6.3 | 7.0 | 20 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 2 | 7.0 | 6.8 | 7.2 | 24 May 2026 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 8 Jul 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 |
| CJC-1295 With DAC | X N/A | 3 | 7.5 | 6.4 | 8.3 | 21 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Jul 2025 |
| Clomid | X N/A | 1 | 7.2 | 7.2 | 7.2 | 2 Jul 2025 |
| COCK BOMBS (Viagra 50mg + Cialis 20mg) | X N/A | 1 | 5.3 | 5.3 | 5.3 | 14 Jan 2025 |
| Crystagen | X N/A | 3 | 6.4 | 4.7 | 7.6 | 20 May 2026 |
| Epithalon | X N/A | 2 | 6.1 | 4.3 | 7.9 | 24 May 2026 |
| Estradiol Cypionate | X N/A | 2 | 6.5 | 5.9 | 7.0 | 20 May 2026 |
| HMG | X N/A | 2 | 5.9 | 4.4 | 7.4 | 17 May 2026 |
| Livagen | X N/A | 3 | 5.6 | 3.8 | 7.7 | 17 May 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 3 | 7.4 | 5.4 | 8.7 | 24 May 2026 |
| NAD+ Injectable | X N/A | 3 | 6.1 | 4.0 | 8.3 | 24 May 2026 |
| NandroMix 300 | X N/A | 3 | 7.2 | 6.0 | 8.9 | 21 May 2026 |
| Ovagen | X N/A | 1 | 8.5 | 8.5 | 8.5 | 24 Apr 2025 |
| Oxytocin Acetate | X N/A | 2 | 6.8 | 6.4 | 7.2 | 19 Jan 2026 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 3 | 6.8 | 5.0 | 10.0 | 17 May 2026 |
| Pancragen | X N/A | 1 | 4.8 | 4.8 | 4.8 | 3 Jul 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 2 | 4.0 | 2.6 | 4.7 | 23 May 2026 |
| PMK methyl glycidate CAS 1369021-80-6 | X N/A | 2 | 7.3 | 6.0 | 8.7 | 24 May 2026 |
| Primobolan E Raw | X N/A | 3 | 6.1 | 4.8 | 6.9 | 26 Jan 2026 |
| Proviron (Mesterolone) | X N/A | 3 | 6.2 | 4.5 | 9.2 | 19 Jan 2026 |
| PTD-DBM | X N/A | 2 | 8.6 | 7.1 | 10.0 | 26 Jan 2026 |
| Semaglutide Raw | X N/A | 1 | 7.5 | 7.5 | 7.5 | 28 Mar 2025 |
| Semax | X N/A | 3 | 7.1 | 6.5 | 8.0 | 17 May 2026 |
| Sildenafil (Viagra) | X N/A | 2 | 8.5 | 7.2 | 9.8 | 24 May 2026 |
| SR9009 | X N/A | 2 | 7.9 | 5.8 | 10.0 | 21 May 2026 |
| T3 (Liothyronine) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 25 Apr 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 3 | 6.6 | 5.0 | 8.0 | 19 Jan 2026 |
| Thymosin Alpha-1 | X N/A | 2 | 5.3 | 3.9 | 6.8 | 21 May 2026 |
| Turinabol | X N/A | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 |
| YK-11 Raw | X N/A | 2 | 5.8 | 5.4 | 6.2 | 24 May 2026 |
Exhibit II
Evidence Log
86 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Estradiol Cypionate | 5.2 B | 100mg/ml | 123.4mg/ml | +23.4% | 99.21% | 8s5be4 | Lab E | Community |
| 25 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.3 A | 5mg | 4.6mg | -8.4% | 95.01% | nti7sh | Lab A | Public |
| 25 May 2026 | Oxytocin Acetate | 8.8 A | 15mg | 17.4mg | +15.8% | 97.06% | 5tmj0t | Lab C | Community |
| 25 May 2026 | Primobolan E Raw | 4.1 C | 100g | 118.7g | +18.7% | 96.58% | wv0tl1 | Lab A | Public |
| 25 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.6 A | 5mg | 5.9mg | +17.7% | 95.37% | kspc9s | Lab A | Public |
| 24 May 2026 | NandroMix 300 | 7.0 A | 200mg/ml | 242.4mg/ml | +21.2% | 99.27% | ciduoa | Lab C | Public |
| 24 May 2026 | Andarine S4 | 9.9 A | 50mg | 46.1mg | -7.9% | 95.55% | lcedkp | Lab D | Public |
| 24 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 5.7 B | 1g | 1.0g | +1.5% | 96.84% | p7b8du | Lab E | Community |
| 24 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.0 C | 100g | 100.7g | +0.7% | 96.76% | o06bnv | Lab G | Community |
| 24 May 2026 | Tirzepatide | 9.5 A | 10mg | 9.8mg | -2.0% | 99.70% | low | No Label / Silver Crimp / Yellow Cap | Lab G |
| 24 May 2026 | Crystagen | 5.3 B | 50mg | 45.1mg | -9.9% | 98.17% | ctdzzf | Lab F | Public |
| 24 May 2026 | BAC Water | 6.2 A | 15mg | 13.8mg | -7.9% | 99.28% | otelf3 | Lab D | Community |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.1 A | 10mg | 10.2mg | +2.0% | 98.45% | 5inpro | Lab A | Community |
| 24 May 2026 | Thymosin Alpha-1 | 6.6 A | 10mg | 10.4mg | +4.4% | 95.60% | 8jo7fr | Lab G | Public |
| 24 May 2026 | Retatrutide | 5.4 C | 40mg | 34.1mg | -14.8% | 99.80% | n/a | No Label / Gold Crimp / Clear Cap | Lab G |
| 24 May 2026 | PMK methyl glycidate CAS 1369021-80-6 | 8.5 A | 100g | 119.1g | +19.1% | 98.75% | 0tvdkb | Lab A | Public |
| 23 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 8.3 A | 20mg | 22.4mg | +11.9% | 98.69% | p9zknb | Lab C | Community |
| 23 May 2026 | Primobolan E Raw | 7.3 A | 1g | 1.1g | +11.9% | 96.71% | 6wtjbn | Lab D | Community |
| 23 May 2026 | PTD-DBM | 7.0 A | 50mg | 60.3mg | +20.7% | 98.71% | zlri7f | Lab F | Community |
| 22 May 2026 | Retatrutide | 6.5 B | 30mg | 32.7mg | +9.0% | 98.78% | n/a | No Label / Silver Crimp / Pink Cap | Lab E |
| 22 May 2026 | Retatrutide | 7.6 A | 30mg | 31.9mg | +6.3% | 99.90% | n/a | No Label / Silver Crimp / Pink Cap | Lab E |
| 21 May 2026 | HMG | 5.5 B | 2mg | 1.8mg | -10.6% | 95.57% | btfkua | Lab B | Public |
| 21 May 2026 | HMG | 6.2 A | 50mg | 60.8mg | +21.6% | 96.66% | ucqsz3 | Lab A | Public |
| 21 May 2026 | NandroMix 300 | 7.2 A | 300mg/ml | 371.8mg/ml | +23.9% | 99.74% | j8qgz2 | Lab B | Community |
| 21 May 2026 | Semax | 7.3 A | 15mg | 13.5mg | -10.3% | 96.51% | 7wjy02 | Lab D | Community |
| 20 May 2026 | Proviron (Mesterolone) | 7.1 A | 50mg | 56.8mg | +13.7% | 98.56% | mpayk7 | Lab D | Public |
| 19 May 2026 | Retatrutide | 7.2 A | 5mg | 5.37mg | +7.4% | 99.90% | n/a | No Label / Silver Crimp / Yellow Cap | Lab E |
| 19 May 2026 | Anavar (Oxandrolone) | 4.8 C | 100mg | 102.9mg | +2.9% | 96.72% | fzhet8 | Lab E | Community |
| 19 May 2026 | COCK BOMBS (Viagra 50mg + Cialis 20mg) | 7.4 A | 25mg | 23.2mg | -7.4% | 99.03% | i1cgvu | Lab G | Community |
| 19 May 2026 | Livagen | 6.4 A | 2mg | 1.9mg | -5.2% | 99.93% | 6yd0k5 | Lab E | Public |
| 19 May 2026 | Turinabol | 10.0 A | 10mg | 9.4mg | -6.1% | 96.22% | jqgz00 | Lab D | Public |
| 17 May 2026 | Crystagen | 4.0 C | 15mg | 18.6mg | +23.7% | 99.89% | 3g7vjr | Lab A | Public |
| 17 May 2026 | Epithalon | 5.1 B | 2mg | 2.3mg | +14.3% | 95.74% | y5prsu | Lab A | Public |
| 17 May 2026 | NAD+ Injectable | 5.9 B | 200mg/ml | 183.8mg/ml | -8.1% | 96.56% | yq68xh | Lab C | Public |
| 17 May 2026 | Sildenafil (Viagra) | 10.0 A | 100mg | 101.3mg | +1.3% | 96.51% | jjuemb | Lab C | Public |
| 29 Jan 2026 | Semax | 7.6 A | 10mg | 10.2mg | +1.5% | 96.08% | oamqe9 | Lab C | Community |
| 26 Jan 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 5.4 B | 100g | 119.2g | +19.2% | 98.59% | zqbte0 | Lab F | Public |
| 26 Jan 2026 | BAC Water | 5.6 B | 50mg | 58.9mg | +17.7% | 98.18% | pwwnjw | Lab C | Public |
| 26 Jan 2026 | Proviron (Mesterolone) | 6.6 A | 10mg | 8.8mg | -11.9% | 98.79% | 9sm3t8 | Lab E | Community |
| 26 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.8 A | 5mg | 4.6mg | -7.1% | 97.97% | 1az3rq | Lab B | Public |
| 19 Jan 2026 | Retatrutide | 8.8 A | 10mg | 10.9mg | +9.0% | 99.95% | n/a | Blue Label / Silver Crimp / Clear Blue Cap | Lab E |
| 19 Jan 2026 | Andarine S4 | 9.1 A | 50mg | 59.9mg | +19.9% | 99.50% | jybunx | Lab E | Community |
| 19 Jan 2026 | CJC-1295 With DAC | 5.0 B | 5mg | 5.1mg | +1.9% | 98.50% | ox3rjx | Lab D | Public |
| 19 Jan 2026 | Oxytocin Acetate | 6.0 A | 30mg | 32.6mg | +8.7% | 97.57% | z7um9e | Lab C | Public |
| 19 Jan 2026 | Pancragen | 4.0 C | 2mg | 2.2mg | +11.4% | 97.14% | a6yk5e | Lab F | Public |
| 9 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.4 A | 100mg/ml | 96.2mg/ml | -3.8% | 96.47% | fxfjkv | Lab F | Public |
| 9 Jan 2026 | Crystagen | 5.7 B | 50mg | 46.2mg | -7.7% | 95.23% | l2r5l6 | Lab C | Community |
| 9 Jan 2026 | N-Acetyl Epitalon Amidate | 6.4 A | 5mg | 5.4mg | +9.0% | 98.12% | 3hnwkz | Lab D | Public |
| 9 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.0 C | 10g | 9.1g | -9.1% | 96.06% | jbjanx | Lab D | Public |
| 7 Jan 2026 | Andarine S4 | 8.9 A | 10mg | 11.3mg | +12.6% | 96.89% | s2b0ll | Lab B | Community |
| 7 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.7 A | 200mg/ml | 176.9mg/ml | -11.6% | 99.35% | 069ozy | Lab D | Community |
| 7 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.3 A | 10mg | 12.0mg | +19.6% | 97.70% | awxwx0 | Lab A | Public |
| 6 Jan 2026 | Estradiol Cypionate | 7.1 A | 100mg/ml | 94.6mg/ml | -5.4% | 97.00% | ei0l8w | Lab E | Public |
| 6 Jan 2026 | Livagen | 6.7 A | 20mg | 21.7mg | +8.3% | 96.38% | ns67xn | Lab B | Public |
| 6 Jan 2026 | Semax | 7.1 A | 2mg | 2.2mg | +9.2% | 96.81% | sai5mk | Lab E | Community |
| 29 Dec 2025 | Alprostadil | 6.7 A | 2mg | 2.3mg | +17.4% | 97.92% | uzfsqc | Lab E | Community |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.3 A | 15mg | 18.4mg | +22.6% | 96.47% | 39q8ag | Lab D | Public |
| 29 Dec 2025 | NAD+ Injectable | 4.6 C | 300mg/ml | 322.8mg/ml | +7.6% | 99.64% | hblfcw | Lab D | Public |
| 29 Dec 2025 | Ovagen | 8.5 A | 20mg | 21.5mg | +7.5% | 97.85% | vpvwjj | Lab E | Public |
| 12 Dec 2025 | YK-11 Raw | 7.7 A | 100g | 97.4g | -2.6% | 95.26% | kaezh8 | Lab G | Public |
| 5 Dec 2025 | Epithalon | 7.7 A | 30mg | 27.2mg | -9.3% | 99.28% | e6znqq | Lab A | Public |
| 5 Dec 2025 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 6.8 A | 1g | 1.0g | +0.4% | 95.13% | 7s1ajl | Lab D | Public |
| 5 Dec 2025 | Sildenafil (Viagra) | 8.3 A | 20mg | 25.0mg | +25.0% | 98.15% | udhwho | Lab C | Public |
| 5 Dec 2025 | SR9009 | 6.9 A | 50mg | 59.5mg | +19.0% | 99.88% | a6bhzh | Lab C | Public |
| 23 Nov 2025 | PMK methyl glycidate CAS 1369021-80-6 | 7.1 A | 500g | 583.4g | +16.7% | 97.63% | td6dwy | Lab D | Community |
| 23 Nov 2025 | PTD-DBM | 9.2 A | 10mg | 11.2mg | +11.9% | 99.44% | r64v6w | Lab F | Public |
| 23 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.9 A | 10mg | 11.7mg | +16.7% | 96.64% | ithrft | Lab C | Community |
| 17 Nov 2025 | Anavar (Oxandrolone) | 4.5 C | 50mg | 58.0mg | +16.1% | 98.70% | c7lwjq | Lab E | Public |
| 17 Nov 2025 | CJC-1295 With DAC | 6.9 A | 20mg | 24.6mg | +23.0% | 99.36% | 7sxhca | Lab C | Community |
| 17 Nov 2025 | Livagen | 4.5 C | 2mg | 2.2mg | +11.0% | 99.47% | uvtbyz | Lab E | Public |
| 17 Nov 2025 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 7.7 A | 10g | 12.5g | +24.7% | 95.87% | xya20x | Lab B | Public |
| 17 Nov 2025 | T3 (Liothyronine) | 6.7 A | 10mg | 8.6mg | -13.6% | 97.36% | f5ejlo | Lab C | Public |
| 5 Nov 2025 | Anavar (Oxandrolone) | 4.3 C | 20mg | 22.3mg | +11.5% | 98.97% | 0go8cg | Lab B | Public |
| 5 Nov 2025 | NandroMix 300 | 8.1 A | 100mg/ml | 104.2mg/ml | +4.2% | 99.09% | 2o32j1 | Lab A | Public |
| 4 Nov 2025 | SR9009 | 8.4 A | 20mg | 20.2mg | +0.9% | 96.05% | pywzlg | Lab B | Public |
| 4 Nov 2025 | Thymosin Alpha-1 | 4.4 C | 15mg | 13.8mg | -8.3% | 95.68% | v1yhlc | Lab A | Community |
| 17 Oct 2025 | BAC Water | 5.3 B | 5mg | 5.2mg | +4.3% | 98.23% | nuvtzs | Lab E | Community |
| 17 Oct 2025 | CJC-1295 With DAC | 6.6 A | 30mg | 31.7mg | +5.5% | 95.82% | bilewj | Lab D | Community |
| 17 Oct 2025 | Clomid | 10.0 A | 20mg | 20.4mg | +1.9% | 97.92% | adretp | Lab F | Community |
| 17 Oct 2025 | NAD+ Injectable | 6.0 A | 200mg/ml | 206.1mg/ml | +3.1% | 99.16% | 6o60a8 | Lab C | Community |
| 17 Oct 2025 | Semaglutide Raw | 7.2 A | 1g | 0.9g | -13.0% | 98.33% | pw9ic4 | Lab B | Community |
| 17 Oct 2025 | YK-11 Raw | 4.9 C | 1g | 1.0g | -0.7% | 97.93% | h2pv6e | Lab B | Public |
| 9 Oct 2025 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 5.6 B | 5g | 5.9g | +17.1% | 97.88% | no43jc | Lab F | Public |
| 9 Oct 2025 | Primobolan E Raw | 5.5 B | 10g | 10.1g | +1.4% | 95.74% | itkmgs | Lab A | Public |
| 9 Oct 2025 | Proviron (Mesterolone) | 5.7 B | 20mg | 20.4mg | +1.8% | 97.98% | yl3zt8 | Lab C | Public |
| 29 Jan 2026⚠️ | Retatrutide | 4.6 D | 23mg | 11.4mg | -50.4% | 99.95% | below LOQ | No Label / Copper Crimp / Clear Cap | Lab E |
— END OF EVIDENCE LOG —